2016 ANNUAL REPORT - AASLD Report.… · AASLD 2016 Governing Board ... Global Forum at The Liver...
10
ANNUAL REPORT 2016
Transcript of 2016 ANNUAL REPORT - AASLD Report.… · AASLD 2016 Governing Board ... Global Forum at The Liver...
ANNUAL REPORT2016
Contents
Treatment Advances & Awareness ............................................ 1
Professional Development ......................................................... 2
Organizational Health ............................................................... 3
AASLD Membership Growth ..................................................... 3
FY2016 Combined Financial Position ........................................ 4
FY2016 Combined Net Assets .................................................. 4
FY2016 Combined Revenue & Expenses ................................... 5
FY2016 Combined Revenue ..................................................... 5
FY2016 Combined Expenses ..................................................... 6
AASLD 2016 Governing Board .................................................. 6
AASLD Foundation 2016 Board of Trustees ............................... 7
In Remembrance ...................................................................... 7
VisionTo Prevent and Cure Liver Disease
AASLD MissionTo advance and disseminate the science and practice of hepatology, and to promote liver health and quality patient care
AASLD Foundation MissionTo invest in innovative hepatology research and in the people who study and treat liver disease.
A A S L D 2 0 1 6 A N N U A L R E P O R T 1
Treatment Advances & Awareness
Clinical Practice Guidelines
Global Outreach & Engagement
Guidelines for the Treatment of Chronic Hepatitis (Includes 3 Systematic Reviews)
Released January 2016
Offered International Travel Awards
Exhibited at ALEH and EASL Annual Meetings
Jointly provided 4 global programs with ALEH, APASL, ASEAN, AND EASL
Co-sponsored programs with: ASEAN, APASL, ASCO/AGA/ASTRO/SSO, FDA/AGA/ACG/
NASPGHAN, AGA, NIH-NIDDK, and FASEB
Endorsed two Highlights of The Liver Meeting programs—SASLT in Saudi
Arabia and Chinese Society of Hepatology
Provided Joint Symposium with APASL and Global Forum at The Liver Meeting 2016
A M E R I C A N A S S O C I AT I O N F O R T H E S T U D Y O F L I V E R D I S E A S E S2
Professional Development
Transplant Hepatology
Review Course
266Participants
AASLD & FDA Workshop Conference
Trial Designs and Endpoints for Clinical Trials in Adults and
Children with PSC 169Participants
10,000+Registrants
2,149Accepted Abstracts
3,800+Postgraduate
Course
3,300Basic Science Symposium
Attendance
AASLD Webinars
Eleven New Webinars in 2016
1,053Registrants
Emerging Trends Conference
Emerging Trends in Alcoholic Hepatitis
120Participants
Clinical Hepatology
Update
149Participants
AASLD/EASL HBV Treatment
Endpoints Workshop
227Participants
A A S L D 2 0 1 6 A N N U A L R E P O R T 3
AASLD Membership Growth
3597 3683
4129
47314978
0
1000
2000
3000
4000
5000
201620152014201320122011
Actual Years:2011: As of 10/22/112012: As of 1/3/132013: As of 1/3/142014: As of 1/5/152015: As of 12/14/152016: As of 1/3/2017
*Discontinued 2013
3597 3683
4129
4731
4978
0
1000
2000
3000
4000
5000 Corporate Affiliate
Emeritus
Associate
International Trainee*
Trainee
International Fellow
Fellow
International
Regular
20152014201320122011
Actual Years:2011: As of 10/22/112012: As of 1/3/132013: As of 1/3/142014: As of 1/5/152015: As of 12/14/15
*Discontinued 2013
Corporate Affiliate
Emeritus
Associate
International Trainee*
Trainee
International Fellow
Fellow
International
Regular
5313
Organizational Health
AASLD Membership Growth
30%Amount AASLD Membership has
grown since 2012
89New AASLD Fellows
(501 Total)
Ensuring the Future of Hepatology
35New Emerging Liver
Scholars (144 since 2012) MOC Taskforce
Number of Matches in the New Mentorship Program
180
A M E R I C A N A S S O C I AT I O N F O R T H E S T U D Y O F L I V E R D I S E A S E S4
FY2016 Combined Financial Position
0
10
20
30
40
50
60
Foundation
AASLD
Net Assets $45MLiabilities $13MAssets $58M
$14
Mill
ion
s
$44
$2
$11
$12
$33
FY2016 Combined Net Assets
Permanently Restricted $4,061,850
Temporarily Restricted $6,074,213
Unrestricted Board Designated $6,434,314
Unrestricted Undesignated $28,353,914
63%14%
14%
9%
A A S L D 2 0 1 6 A N N U A L R E P O R T 5
FY2016 Combined Revenue
FY2016 Combined Revenue & Expenses
Revenue $16,002,637
Loss from Investments -$461,669
Expenses -$16,961,770
Surplus/Loss -$1,420,802
Annual Meeting ($8.7M)
Research & Fellowship Awards ($1.9M)
Publications ($2.8M)
Membership ($1.5M)
Meetings & Education ($771K)
Professional Relations, Fundraising & Other ($267K)
Rental Income ($104K)
54%
12%
17%
9%
5%
2% 1%
For full financial statements refer to aasld.org
A M E R I C A N A S S O C I AT I O N F O R T H E S T U D Y O F L I V E R D I S E A S E S6
FY2016 Combined Expenses
AASLD 2016 Governing Board
PresidentKeith D. Lindor, MD, FAASLDArizona State UniversityPhoenix, AZ
President-ElectAnna SF Lok, MD, FAASLDUniversity of MichiganAnn Arbor, MI
SecretaryKimberly Ann Brown, MD, FAASLDHenry Ford Health SystemDetroit, MI
TreasurerW. Ray Kim, MD, MBA, FAASLDStanford UniversityStanford, CA
Past-PresidentGyongyi Szabo MD, PhD, FAASLDUniversity of MassachusettsWorcester, MA
CouncilorsRonald J. Sokol, MD, FAASLDUniversity of ColoradoAurora, CO
Michael W. Fried, MD, FAASLDUniversity of North CarolinaChapel Hill, NC
Jorge A Bezerra, MD, FAASLDCincinnati Children’s HospitalCincinnati, OH
Councilors- At-Large
K. Rajender Reddy, MD, FAASLDUniversity of PennsylvaniaPhiladelphia, PA
Mark J. Czaja, MD, FAASLDEmory UniversityAtlanta, GA
Julie Heimbach, MDMayo ClinicRochester, MN
26%
18%12%
8%12%
14%
6%
4%
Fundraising ($64K)
Leadership, IT, F&A ($2.4M)
Policies and Communications ($919K)
Professional Relations ($615K)
Meetings & Education ($2M)
Membership ($1.3M)
Publications ($1.9M)
Research & Fellowship Awards ($3M)
Annual Meeting ($4.2M)
AASLD & AASLD Foundation spends 86% on Programs service functions and 14% on leadership, administration and fundraising.
A A S L D 2 0 1 6 A N N U A L R E P O R T 7
In RemembranceKris Krawczynski, MD
Anthony Tavill, MD
AASLD Foundation 2016 Board of Trustees
ChairBruce R. Bacon, MD, FAASLDSaint Louis UniversitySt. Louis, MO
TreasurerW. Ray Kim, MD, MBA, FAASLDStanford UniversityStanford, CA
TrusteesSteven L. Flamm, MDNorthwestern University Health SystemChicago, IL
Michael W Fried, MD, FAASLDUniversity of North Carolina at Chapel HillChapel Hill, NC
Cara Lynn Mack, MDUniversity of Colorado School of MedicineAurora, CO
K. Rajender Reddy, MD, FAASLDUniversity of PennsylvaniaPhiladelphia, PA
Arun J. Sanyal, MD, FAASLDVirginia Commonwealth UniversityRichmond, VA
Gyongyi Szabo, MD, PhD, FAASLDUniversity of Massachusetts Medical SchoolSouthborough, MA
Executive DirectorJulie A. Deal
AASLD is the professional home
for the innovators, educators, and
clinicians in hepatology.
1001 North Fairfax Street, Suite 400 | Alexandria, VA 22314 Phone: 703-299-9766 | Fax: 703-299-9622 | www.aasld.org
